Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Notes Payables (2020 - 2021)

Historic Notes Payables for Capricor Therapeutics (CAPR) over the last 3 years, with Q1 2021 value amounting to $282691.0.

  • Capricor Therapeutics' Notes Payables changed N/A to $282691.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $282691.0, marking a year-over-year change of. This contributed to the annual value of $246689.0 for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q1 2021, Capricor Therapeutics' Notes Payables is $282691.0.
  • Capricor Therapeutics' Notes Payables' 5-year high stood at $282691.0 during Q1 2021, with a 5-year trough of $139927.0 in Q2 2020.